ASCO Publications
ASCO’s publications—including the Society’s flagship publication, the Journal of Clinical Oncology —serve readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research that informs the …
Journal of Clinical Oncology - ASCO Publications
Oct 31, 2024 · A world where cancer is prevented or cured. Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and …
ASCO Clinical Practice Guidelines | Journal of Clinical …
Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented). Using the best available evidence, ASCO expert panels identify and develop practice …
Journal of Clinical Oncology: Vol 42, No 32 - ASCO Publications
Oct 3, 2024 · CORRESPONDENCE. Rectal Relief: Proton Therapy's Impact on Urgency and Frequency. View Past Issues. Nov 1, 2024. Volume 42 Issue 31. Oct 20, 2024. Volume 42 …
JCO Oncology Practice - ASCO Publications
Sep 3, 2024 · A world where cancer is prevented or cured. Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in …
Updated Guideline for Advanced NSCLC With Driver Mutations …
1 day ago · Dr. Lyudmila Bazhenova Key Points: In the first-line setting, the guideline now recommends that clinicians should offer osimertinib for patients with EGFR exon 19 deletions …
Palliative Care for Patients With Cancer: ASCO …
May 15, 2024 · 1. Clinicians should refer patients with advanced solid tumors and hematologic malignancies to specialized interdisciplinary palliative care teams that provide inpatient and outpatient care early in the course of disease, …
ASCO Annual Meeting | ASCO Daily News
June 19, 2024. Dr. Diwakar Davar and Dr. Jason Luke discuss advances in the neoadjuvant immunotherapy space that were presented at the 2024 ASCO Annual Meeting, including promising outcomes in high-risk melanoma from the …
Use of Opioids for Adults With Pain From Cancer or …
Pain remains a common consequence of cancer and its treatment. Approximately 55% of those undergoing active treatment experience pain, while the prevalence is > 66% in people with advanced disease. 1 In most cases, moderate-to …
Vaccination of Adults With Cancer: ASCO Guideline
Mar 18, 2024 · 60 years and older: immunize those with other risk factors c. For adults 20 years and older, use high antigen (40 µg) and administer as a three-dose Recombivax HB series (0, …